References

1. 1.
   MA L Y，WANG Z W，FAN J，et al.Epidemiology and management of hypertension in China： An analysis using data from the Annual Report on Cardiovascular Health and Diseases in China（2021）［J］.Chin General Pract，2022，25（30）：3715-3720.
2. 2.
   ZHANG M，SHI Y，ZHOU B，et al.Prevalence，awareness，treatment，and control of hypertension in China，2004-18：findings from six rounds of a national survey［J］.BMJ，2023，380：e071952.
3. 3.
   QIAO L J，LI B，WANG Y X，et al.Evidence mapping of clinical research on prevention and treatment of essential hypertension with Chinese patent medicines in recent six years［J］.China J Chin Mater Med，2022，47（19）：5375-5382.
4. 4.
   WANG Y C，ZHANG Y M，XU X D，et al.Gouteng prescription treats primary hypertension with anxiety disorder in patients with syndrome of Yang hyperactivity and heat toxin：Clinical efficacy and impact on balance of inflammatory cytokines［J］.Chin J Exp Tradit Med Form，2023，29（24）：138-145
5. 5.
   LUAN H Q.Clinical research progress of traditional Chinese medicine in the treatment of hypertensive cerebral hemorrhage［J］.Guangming J Chin Med，2016，31（18）：2751-2753.
6. 6.
   ZHANG Y H，QIN Y，SHAO G.Effect of Huatan Tongluo prescription on vulnerability of carotid atherosclerotic plaque in hypertension［J］.Chin J Exp Tradit Med Form，2023，29（19）：151-159.
7. 7.
   LIU H.Research progress on identification of antelope horn medicinal materials［J］.Guangming J Chin Med，2022，37（16）：3060-3062.
8. 8.
   ZHAO X W，SONG F B，MAO K C.Clinical application of antelope horn［J］.Capital Food Med，2019，26（18）：190-191.
9. 9.
   YUE C M，XIAO Y L，LONG X H，et al.Tongren Niuhuang Qingxin pills in treating hypertensive vertigo of phlegm-heat invading upward type［J］.Chin Med Mod Distance Edu China，2024，22（1）：76-79.
10. 10.
    FANG X J，QIAN B Q.Impact of saiga horn capsule on blood pressure variability，pulse pressure and left ventricular mass in elderly patients with isolated systolic hypertension［J］.China J Tradit Chin Med Pharm，2010，25（6）：936-938.
11. 11.
    MENG Z B.Explanations on the CITES and the domestic policies in relation to saiga （Saiga tatarica）［J］.Mod Chin Med，2011，13（7）：3-5.
12. 12.
    WU W X，LIU R，ZHAO J J，et al.Research progress on medicinal value of goat horn［J］.Chin Tradit Herbal Drugs，2022，53（9）：2825-2838.
13. 13.
    LIU R，ZHU Z，QIAN D，et al.Comparison of the peptidome released from keratins in Saiga antelope horn and goat horn under simulated gastrointestinal digestion［J］.Electrophoresis，2019，40（20）：2759-2766.
14. 14.
    CHEN F R，SHANG D D，JIANG X，et al.Experimental study on horns of Capra hircus instead of horns of Saiga tataria［J］.Drug Evaluation Res，2015，38（1）：49-52.
15. 15.
    JIANG Q H，ZHAI Y J.Pharmacological action comparison between Cornu antelopis and Cornu caprae hircus［J］.Shanxi Med J，2006，34（7）：582-583.
16. 16.
    LI P F，LI Y Q，MA Q T，et al.Experimental study on pharmacodynamics of Lingyang Qingfei granule（endangered substitute）［J］.Guiding J Tradit Chin Med Pharm，2020，26（4）：24-29.
17. 17.
    SI Y P.Using the classical theory of traditional Chinese medicine dialectical treatment of hypertension［J］.Inner Mongolia J Tradit Chin Med，2019，38（5）：79-80.
18. 18.
    ZHAO Q，WEI H.Pharmacology and traditional Chinese medicine pharmacology experimental guidance［M］.Xi'an： Shanxi Science and Technology Press，2014.
19. 19.
    LV G Y，CHEN S H，CHEN N，et al.The effects of Lingjiaojiangyafang and its disassembled on the symptoms of ganyangshangkang hypertension［J］.Chin Pharmacol Bull，2010，26（11）：1532-1534.
20. 20.
    YAO X D，LU Y Z，ZHU C H，et al.Clinical observation on treatment of 50 cases of hypertension with hyperactivity of liver-Yang by antelope horn decoction combined with valsartan amlodipine tablet［J］.Cardiovascul Dis Electronic J Integr Tradit Chin Western Med，2016，4（20）：168-169.
21. 21.
    WANG M，ZHOU X J.Research progress of traditional Chinese medicine treatment of resistant hypertension［J］.Asia-Pacific Tradit Med，2024，20（2）：245-250.
22. 22.
    TE RIET L，VAN ESCH J H，ROKS A J，et al.Hypertension： renin-angiotensin-aldosterone system alterations［J］.Circ Res，2015，116（6）：960-975.
23. 23.
    MENNUNI S，RUBATTU S，PIERELLI G，et al.Hypertension and kidneys： Unraveling complex molecular mechanisms underlying hypertensive renal damage［J］.J Hum Hypertens，2014，28（2）：74-79.
24. 24.
    SOUTH A M，SHALTOUT H A，WASHBURN L K，et al.Fetal programming and the angiotensin-（1-7） axis：A review of the experimental and clinical data［J］.Clin Sci （Lond），2019，133（1）：55-74.
25. 25.
    ZHANG Y Y，JIN P P，BIAN D，et al.Mechanism of modified Zhenwutang in delaying renal interstitial fibrosis in chronic renal failure based on Ang Ⅱ/AT1R/NOX4 signaling pathway［J］.Chin J Exp Tradit Med Form，2023，29（16）：89-99.
26. 26.
    PAN X，SHAO Y，WU F，et al.FGF21 prevents angiotensin Ⅱ-induced hypertension and vascular dysfunction by activation of ACE2/Angiotensin-（1-7） axis in mice［J］.Cell Metab，2018，27（6）：1323-1337.
27. 27.
    HU J Y，ZHU Y，LIU J F，et al.Study on the antihypertensive effect of compound Gaoziban tablet on spontaneous hypertension rats and the regulation mechanism of RAAS［J］.World Sci Technol Mod Tradit Chin Med，2021，23（7）：2227-2236.
28. 28.
    AGITA A，ALSAGAFF M T.Inflammation， immunity， and hypertension［J］.Acta Med Indones，2017，49（2）：158-165.
29. 29.
    ZHANG Z，ZHAO L，ZHOU X，et al.Role of inflammation， immunity，and oxidative stress in hypertension：New insights and potential therapeutic targets［J］.Front Immunol，2023，13：1098725.
30. 30.
    BIANCARDI V C，BOMFIM G F，REIS W L，et al.The interplay between angiotensin Ⅱ，TLR4 and hypertension［J］.Pharmacol Res，2017，120：88-96.
31. 31.
    DANGE R B， AGARWAL D，MASSON G S，et al.Central blockade of TLR4 improves cardiac function and attenuates myocardial inflammation in angiotensin Ⅱ-induced hypertension［J］.Cardiovasc Res，2014，103（1）：17-27.
32. 32.
    TAN S，XU M，KE B，et al.IL-6-driven FasL promotes NF-κB p65/PUMA-mediated apoptosis in portal hypertensive gastropathy［J］.Cell Death Dis，2019，10（10）：748.
33. 33.
    LIN Y M，BADREALAM K F，KUO W W，et al.Nerolidol improves cardiac function in spontaneously hypertensive rats by inhibiting cardiac inflammation and remodelling associated TLR4/NF-κB signalling cascade［J］.Food Chem Toxicol，2021，147：111837.
34. 34.
    LI Y T，LEI Z Q，YOU Y，et al.Mechanism of Buyang Huanwutang in regulating macrophage cell polarization based on TLR4/NF-κB/NLRP3 Pathway［J］.Chin J Exp Tradit Med Form，2023，29（19）：18-25.